Fig. 5: CAR-T cell pharmacokinetics and B cell persistence. | Blood Cancer Journal

Fig. 5: CAR-T cell pharmacokinetics and B cell persistence.

From: Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial

Fig. 5

A CAR-T cell number in peripheral blood mononuclear cells (PBMCs). Absolute counts of CAR-T cells in peripheral blood were measured using flow cytometry. B Presence of CAR-expressing T cells among lymphocytes as quantified by flow cytometry. C Percentage of CD19+ cells among lymphocytes as quantified by flow cytometry.

Back to article page